 Lori Walker
Concepts (411)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ventricular Dysfunction, Right | 5 | 2019 | 192 | 2.250 |
Why?
| | Heart Ventricles | 10 | 2019 | 754 | 1.960 |
Why?
| | Myocardium | 18 | 2017 | 1104 | 1.910 |
Why?
| | Troponin I | 11 | 2019 | 80 | 1.530 |
Why?
| | Myocytes, Cardiac | 12 | 2019 | 503 | 1.110 |
Why?
| | Hypertrophy, Right Ventricular | 2 | 2016 | 129 | 1.080 |
Why?
| | Ventricular Function, Right | 4 | 2019 | 237 | 1.050 |
Why?
| | Hypertension, Pulmonary | 7 | 2019 | 1705 | 1.010 |
Why?
| | Myocardial Infarction | 9 | 2021 | 1186 | 0.900 |
Why?
| | Cattle | 5 | 2019 | 972 | 0.880 |
Why?
| | Actin Cytoskeleton | 7 | 2011 | 91 | 0.870 |
Why?
| | Myosin Light Chains | 8 | 2013 | 34 | 0.790 |
Why?
| | Phosphorylation | 25 | 2019 | 1754 | 0.790 |
Why?
| | Cell Dedifferentiation | 1 | 2019 | 31 | 0.760 |
Why?
| | Protein Processing, Post-Translational | 6 | 2016 | 427 | 0.760 |
Why?
| | Myocardial Contraction | 11 | 2019 | 385 | 0.690 |
Why?
| | Fibroblasts | 2 | 2019 | 886 | 0.630 |
Why?
| | Calcium | 16 | 2019 | 1235 | 0.630 |
Why?
| | Disease Models, Animal | 10 | 2019 | 3894 | 0.630 |
Why?
| | Muscle, Smooth | 8 | 2007 | 141 | 0.620 |
Why?
| | Muscle Proteins | 4 | 2011 | 238 | 0.620 |
Why?
| | Cardiac Myosins | 3 | 2013 | 32 | 0.610 |
Why?
| | Ventricular Remodeling | 6 | 2019 | 213 | 0.580 |
Why?
| | Period Circadian Proteins | 5 | 2021 | 28 | 0.570 |
Why?
| | Cardiomegaly | 2 | 2013 | 175 | 0.550 |
Why?
| | Ventricular Dysfunction, Left | 5 | 2012 | 394 | 0.550 |
Why?
| | Interleukin-18 | 1 | 2016 | 241 | 0.520 |
Why?
| | Mitochondria | 2 | 2020 | 834 | 0.480 |
Why?
| | Protein Disulfide-Isomerases | 1 | 2012 | 8 | 0.470 |
Why?
| | Blotting, Western | 3 | 2015 | 1296 | 0.440 |
Why?
| | Muscle, Smooth, Vascular | 7 | 2016 | 479 | 0.430 |
Why?
| | Antibodies | 2 | 2013 | 422 | 0.430 |
Why?
| | Animals | 47 | 2021 | 35392 | 0.400 |
Why?
| | Cardiovascular Diseases | 2 | 2021 | 1743 | 0.390 |
Why?
| | Hypoxia | 2 | 2016 | 948 | 0.390 |
Why?
| | Protein Kinase C | 5 | 2014 | 349 | 0.390 |
Why?
| | Phenotype | 6 | 2013 | 2938 | 0.390 |
Why?
| | Myocardial Ischemia | 3 | 2021 | 315 | 0.380 |
Why?
| | Aortic Valve Stenosis | 1 | 2013 | 315 | 0.360 |
Why?
| | Muscle Contraction | 8 | 2014 | 431 | 0.350 |
Why?
| | Myosin Heavy Chains | 4 | 2017 | 196 | 0.350 |
Why?
| | Tissue and Organ Procurement | 1 | 2010 | 223 | 0.340 |
Why?
| | Heart Failure | 6 | 2014 | 2010 | 0.340 |
Why?
| | Aorta | 3 | 2018 | 415 | 0.310 |
Why?
| | Exercise | 1 | 2018 | 1816 | 0.300 |
Why?
| | Gene Expression | 5 | 2016 | 1550 | 0.280 |
Why?
| | Serine | 3 | 2013 | 133 | 0.260 |
Why?
| | Receptor, Adenosine A2B | 2 | 2015 | 30 | 0.260 |
Why?
| | Adaptation, Physiological | 3 | 2018 | 538 | 0.250 |
Why?
| | Heart | 3 | 2017 | 710 | 0.250 |
Why?
| | Signal Transduction | 12 | 2020 | 4919 | 0.240 |
Why?
| | rho-Associated Kinases | 2 | 2015 | 85 | 0.220 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2014 | 248 | 0.220 |
Why?
| | Mice | 20 | 2017 | 15850 | 0.220 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2017 | 189 | 0.210 |
Why?
| | Point Mutation | 2 | 2001 | 239 | 0.210 |
Why?
| | Protein-Tyrosine Kinases | 5 | 1999 | 456 | 0.210 |
Why?
| | Cardiomyopathy, Dilated | 2 | 2019 | 356 | 0.200 |
Why?
| | Circadian Clocks | 1 | 2021 | 58 | 0.200 |
Why?
| | Catechin | 1 | 2020 | 30 | 0.200 |
Why?
| | rhoA GTP-Binding Protein | 5 | 2008 | 80 | 0.200 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 4 | 2011 | 142 | 0.190 |
Why?
| | MicroRNAs | 3 | 2017 | 631 | 0.190 |
Why?
| | Gene Expression Regulation | 3 | 2021 | 2576 | 0.190 |
Why?
| | Electron Transport Complex I | 2 | 2020 | 40 | 0.180 |
Why?
| | Rats | 10 | 2018 | 6278 | 0.180 |
Why?
| | Isoflavones | 4 | 1995 | 26 | 0.180 |
Why?
| | Reperfusion Injury | 1 | 2021 | 291 | 0.180 |
Why?
| | Glycolysis | 2 | 2017 | 234 | 0.170 |
Why?
| | Cardiorespiratory Fitness | 1 | 2018 | 46 | 0.170 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 1 | 2018 | 69 | 0.170 |
Why?
| | Molecular Targeted Therapy | 1 | 2021 | 382 | 0.170 |
Why?
| | Male | 26 | 2019 | 61786 | 0.160 |
Why?
| | Isoenzymes | 1 | 1998 | 354 | 0.160 |
Why?
| | Vasoconstriction | 2 | 2018 | 233 | 0.160 |
Why?
| | Carotid Arteries | 1 | 2018 | 187 | 0.160 |
Why?
| | Protein Kinase C-epsilon | 4 | 2006 | 31 | 0.150 |
Why?
| | Myocardial Reperfusion Injury | 2 | 2015 | 155 | 0.150 |
Why?
| | Protein Phosphatase 1 | 2 | 2013 | 28 | 0.150 |
Why?
| | Protein Phosphatase 2 | 2 | 2013 | 34 | 0.150 |
Why?
| | Swine | 3 | 2013 | 725 | 0.150 |
Why?
| | Physical Conditioning, Animal | 1 | 2018 | 231 | 0.150 |
Why?
| | Up-Regulation | 2 | 2017 | 943 | 0.150 |
Why?
| | Chemokine CXCL12 | 1 | 2016 | 79 | 0.150 |
Why?
| | Cellular Reprogramming Techniques | 1 | 2015 | 15 | 0.140 |
Why?
| | Carrier Proteins | 4 | 2019 | 809 | 0.140 |
Why?
| | Phenylephrine | 5 | 2014 | 109 | 0.140 |
Why?
| | Hemodynamics | 2 | 2011 | 1117 | 0.140 |
Why?
| | Amino Acid Substitution | 3 | 2009 | 285 | 0.140 |
Why?
| | Phosphofructokinase-1 | 1 | 2014 | 19 | 0.140 |
Why?
| | Calcium Signaling | 3 | 2014 | 233 | 0.140 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2016 | 173 | 0.140 |
Why?
| | Glucose Transporter Type 4 | 1 | 2014 | 40 | 0.140 |
Why?
| | Anion Transport Proteins | 1 | 2014 | 11 | 0.140 |
Why?
| | Mitochondria, Muscle | 1 | 2016 | 102 | 0.140 |
Why?
| | Humans | 23 | 2021 | 119016 | 0.130 |
Why?
| | Cellular Reprogramming | 1 | 2015 | 93 | 0.130 |
Why?
| | Myosin-Light-Chain Kinase | 4 | 2006 | 26 | 0.130 |
Why?
| | Mice, Knockout | 3 | 2016 | 2862 | 0.130 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2016 | 207 | 0.130 |
Why?
| | Light | 1 | 2017 | 368 | 0.130 |
Why?
| | Unfolded Protein Response | 1 | 2014 | 45 | 0.130 |
Why?
| | Angiotensin II | 1 | 2014 | 111 | 0.130 |
Why?
| | Cells, Cultured | 5 | 2019 | 4312 | 0.130 |
Why?
| | Circadian Rhythm | 2 | 2021 | 463 | 0.130 |
Why?
| | DNA Copy Number Variations | 1 | 2014 | 149 | 0.130 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2016 | 241 | 0.130 |
Why?
| | GTP-Binding Proteins | 3 | 1999 | 154 | 0.130 |
Why?
| | Antibody Specificity | 1 | 2013 | 193 | 0.120 |
Why?
| | Collagen | 1 | 2016 | 434 | 0.120 |
Why?
| | Oxidative Stress | 1 | 2020 | 1239 | 0.120 |
Why?
| | Endothelium, Vascular | 1 | 2020 | 973 | 0.120 |
Why?
| | Mice, Inbred C57BL | 4 | 2017 | 5227 | 0.120 |
Why?
| | Palmitic Acid | 1 | 2012 | 50 | 0.120 |
Why?
| | Transforming Growth Factor beta | 1 | 2015 | 473 | 0.120 |
Why?
| | Immunodominant Epitopes | 1 | 2012 | 27 | 0.120 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2012 | 53 | 0.120 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2012 | 38 | 0.110 |
Why?
| | RNA, Messenger | 5 | 2014 | 2876 | 0.110 |
Why?
| | Models, Biological | 1 | 2020 | 1814 | 0.110 |
Why?
| | Protein Array Analysis | 1 | 2012 | 62 | 0.110 |
Why?
| | Guanine Nucleotide Dissociation Inhibitors | 3 | 2000 | 3 | 0.110 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2014 | 531 | 0.110 |
Why?
| | Monocrotaline | 2 | 2008 | 32 | 0.110 |
Why?
| | src-Family Kinases | 1 | 2012 | 98 | 0.110 |
Why?
| | Ventricular Pressure | 1 | 2011 | 41 | 0.110 |
Why?
| | Excitation Contraction Coupling | 1 | 2011 | 18 | 0.110 |
Why?
| | Adrenergic beta-1 Receptor Agonists | 1 | 2010 | 6 | 0.110 |
Why?
| | Desmin | 1 | 2010 | 33 | 0.110 |
Why?
| | Hyperbaric Oxygenation | 1 | 2011 | 50 | 0.110 |
Why?
| | Myofibrils | 1 | 2011 | 51 | 0.100 |
Why?
| | Protein Kinases | 3 | 2020 | 336 | 0.100 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2012 | 171 | 0.100 |
Why?
| | Antigen Presentation | 1 | 2012 | 214 | 0.100 |
Why?
| | Microcystins | 2 | 2001 | 9 | 0.100 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2012 | 204 | 0.100 |
Why?
| | Autophagy | 1 | 2014 | 323 | 0.100 |
Why?
| | Histone Deacetylases | 1 | 2012 | 210 | 0.100 |
Why?
| | Fatty Acids | 1 | 2013 | 441 | 0.100 |
Why?
| | Receptors, Adrenergic, beta | 1 | 2010 | 159 | 0.100 |
Why?
| | Recovery of Function | 2 | 2011 | 616 | 0.100 |
Why?
| | Endoplasmic Reticulum | 1 | 2012 | 256 | 0.100 |
Why?
| | Bisoprolol | 1 | 2009 | 5 | 0.090 |
Why?
| | Tyrosine | 3 | 1995 | 246 | 0.090 |
Why?
| | Rats, Wistar | 3 | 2018 | 405 | 0.090 |
Why?
| | Biopsy | 1 | 2013 | 1076 | 0.090 |
Why?
| | Cardiomyopathy, Hypertrophic, Familial | 1 | 2009 | 17 | 0.090 |
Why?
| | Isoelectric Focusing | 2 | 2006 | 39 | 0.090 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2009 | 88 | 0.090 |
Why?
| | Rabbits | 5 | 2001 | 798 | 0.090 |
Why?
| | Animals, Newborn | 1 | 2011 | 855 | 0.090 |
Why?
| | Peptide Fragments | 4 | 2018 | 741 | 0.090 |
Why?
| | Predictive Value of Tests | 1 | 2013 | 2005 | 0.090 |
Why?
| | Reproducibility of Results | 3 | 2013 | 2977 | 0.090 |
Why?
| | Peptides | 3 | 2001 | 888 | 0.090 |
Why?
| | Dehydroepiandrosterone | 1 | 2008 | 54 | 0.090 |
Why?
| | Time Factors | 6 | 2012 | 7099 | 0.080 |
Why?
| | Peptides, Cyclic | 2 | 2001 | 262 | 0.080 |
Why?
| | Amino Acid Sequence | 1 | 2012 | 2163 | 0.080 |
Why?
| | Nitriles | 2 | 1995 | 167 | 0.080 |
Why?
| | Superoxides | 2 | 2020 | 243 | 0.080 |
Why?
| | Smooth Muscle Myosins | 1 | 2007 | 9 | 0.080 |
Why?
| | Ileum | 3 | 2001 | 92 | 0.080 |
Why?
| | Cardiac Output, Low | 1 | 2007 | 78 | 0.080 |
Why?
| | In Vitro Techniques | 6 | 2011 | 1236 | 0.080 |
Why?
| | Sex Factors | 1 | 2013 | 1993 | 0.080 |
Why?
| | Molecular Sequence Data | 1 | 2012 | 3018 | 0.080 |
Why?
| | Guanosine 5'-O-(3-Thiotriphosphate) | 4 | 2000 | 18 | 0.080 |
Why?
| | Adjuvants, Immunologic | 1 | 2008 | 238 | 0.080 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2009 | 373 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2009 | 464 | 0.080 |
Why?
| | Echocardiography | 1 | 2009 | 640 | 0.070 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2006 | 112 | 0.070 |
Why?
| | Energy Metabolism | 1 | 2012 | 941 | 0.070 |
Why?
| | Portal Vein | 4 | 2000 | 93 | 0.070 |
Why?
| | Hypercapnia | 1 | 2005 | 46 | 0.070 |
Why?
| | Heart-Assist Devices | 1 | 2011 | 459 | 0.070 |
Why?
| | Female | 10 | 2017 | 64422 | 0.070 |
Why?
| | Case-Control Studies | 1 | 2013 | 3330 | 0.070 |
Why?
| | Antibodies, Monoclonal | 1 | 2012 | 1325 | 0.070 |
Why?
| | Muscle Relaxation | 2 | 2001 | 33 | 0.070 |
Why?
| | Phosphoserine | 1 | 2004 | 38 | 0.070 |
Why?
| | Urinary Bladder | 1 | 2007 | 156 | 0.070 |
Why?
| | Ventricular Function, Left | 2 | 2006 | 502 | 0.070 |
Why?
| | Systole | 1 | 2005 | 196 | 0.070 |
Why?
| | Down-Regulation | 2 | 1998 | 671 | 0.070 |
Why?
| | Genistein | 4 | 1995 | 26 | 0.070 |
Why?
| | Colforsin | 2 | 2001 | 71 | 0.070 |
Why?
| | Disease Progression | 2 | 2009 | 2524 | 0.070 |
Why?
| | Cell Proliferation | 1 | 2012 | 2382 | 0.060 |
Why?
| | Vanadates | 1 | 1993 | 30 | 0.060 |
Why?
| | Liver | 1 | 2012 | 1873 | 0.060 |
Why?
| | Oxidation-Reduction | 2 | 2020 | 985 | 0.060 |
Why?
| | Tyrphostins | 1 | 1993 | 17 | 0.060 |
Why?
| | Mice, Transgenic | 5 | 2007 | 2135 | 0.060 |
Why?
| | Biomarkers | 1 | 2013 | 3583 | 0.060 |
Why?
| | Serotonin | 1 | 1995 | 387 | 0.060 |
Why?
| | Catecholamines | 2 | 2014 | 121 | 0.060 |
Why?
| | Severity of Illness Index | 1 | 2011 | 2885 | 0.060 |
Why?
| | Inflammation | 1 | 2013 | 2549 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 4 | 2012 | 2992 | 0.060 |
Why?
| | Immunohistochemistry | 2 | 2017 | 1802 | 0.060 |
Why?
| | Potassium Chloride | 2 | 2014 | 52 | 0.050 |
Why?
| | Phosphoric Monoester Hydrolases | 2 | 1999 | 58 | 0.050 |
Why?
| | Culture Techniques | 1 | 2001 | 93 | 0.050 |
Why?
| | Aspartic Acid | 1 | 2001 | 89 | 0.050 |
Why?
| | Cyclic GMP | 1 | 2001 | 127 | 0.050 |
Why?
| | Sarcomeres | 2 | 2011 | 89 | 0.050 |
Why?
| | Antimycin A | 1 | 2020 | 11 | 0.050 |
Why?
| | Microscopy, Electron | 1 | 2001 | 447 | 0.050 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2020 | 43 | 0.050 |
Why?
| | Binding Sites | 2 | 2001 | 1303 | 0.050 |
Why?
| | Cell Respiration | 1 | 2020 | 79 | 0.050 |
Why?
| | Immunoassay | 1 | 2000 | 107 | 0.050 |
Why?
| | Guanosine Triphosphate | 1 | 2000 | 92 | 0.050 |
Why?
| | Guinea Pigs | 3 | 1995 | 161 | 0.050 |
Why?
| | Plasminogen Activators | 1 | 1999 | 10 | 0.050 |
Why?
| | Sirtuin 3 | 1 | 2020 | 49 | 0.050 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2020 | 94 | 0.050 |
Why?
| | Urokinase-Type Plasminogen Activator | 1 | 1999 | 37 | 0.050 |
Why?
| | Enzyme Activation | 3 | 2009 | 961 | 0.050 |
Why?
| | Nitric Oxide | 2 | 2016 | 909 | 0.050 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2020 | 201 | 0.050 |
Why?
| | Phosphotransferases | 1 | 1999 | 33 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 1999 | 127 | 0.050 |
Why?
| | Integrins | 1 | 1999 | 84 | 0.050 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2012 | 319 | 0.050 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 180 | 0.050 |
Why?
| | Myosin-Light-Chain Phosphatase | 1 | 1998 | 4 | 0.050 |
Why?
| | Ferrets | 1 | 1998 | 15 | 0.040 |
Why?
| | Kinetics | 3 | 2011 | 1766 | 0.040 |
Why?
| | Middle Aged | 4 | 2013 | 29243 | 0.040 |
Why?
| | ras Proteins | 1 | 1999 | 149 | 0.040 |
Why?
| | MAP Kinase Signaling System | 1 | 2000 | 320 | 0.040 |
Why?
| | Phosphoprotein Phosphatases | 1 | 1998 | 67 | 0.040 |
Why?
| | ADP Ribose Transferases | 1 | 1997 | 10 | 0.040 |
Why?
| | Dobutamine | 2 | 2010 | 37 | 0.040 |
Why?
| | Mitochondria, Heart | 1 | 2018 | 91 | 0.040 |
Why?
| | Diphtheria Toxin | 1 | 1997 | 79 | 0.040 |
Why?
| | Phosphofructokinases | 1 | 2017 | 2 | 0.040 |
Why?
| | Adenosine Diphosphate | 1 | 1997 | 98 | 0.040 |
Why?
| | Blood Pressure | 3 | 2012 | 1749 | 0.040 |
Why?
| | Ischemic Preconditioning | 1 | 2017 | 18 | 0.040 |
Why?
| | Pyrans | 1 | 1997 | 5 | 0.040 |
Why?
| | Spiro Compounds | 1 | 1997 | 10 | 0.040 |
Why?
| | Botulinum Toxins | 1 | 1997 | 42 | 0.040 |
Why?
| | Exercise Tolerance | 1 | 2018 | 247 | 0.040 |
Why?
| | Aged | 2 | 2013 | 20607 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2014 | 2197 | 0.040 |
Why?
| | GATA4 Transcription Factor | 1 | 2015 | 24 | 0.040 |
Why?
| | MEF2 Transcription Factors | 1 | 2015 | 65 | 0.040 |
Why?
| | Ischemic Preconditioning, Myocardial | 1 | 2015 | 55 | 0.040 |
Why?
| | rho-Specific Guanine Nucleotide Dissociation Inhibitors | 3 | 2000 | 3 | 0.040 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2015 | 142 | 0.040 |
Why?
| | T-Box Domain Proteins | 1 | 2015 | 84 | 0.030 |
Why?
| | Glucose | 1 | 2020 | 941 | 0.030 |
Why?
| | Receptor, Angiotensin, Type 1 | 1 | 2014 | 23 | 0.030 |
Why?
| | Phosphotyrosine | 2 | 1995 | 41 | 0.030 |
Why?
| | Adoptive Transfer | 1 | 2015 | 209 | 0.030 |
Why?
| | Vasodilation | 1 | 2018 | 488 | 0.030 |
Why?
| | Organ Specificity | 1 | 2015 | 300 | 0.030 |
Why?
| | Embryo, Mammalian | 1 | 2015 | 242 | 0.030 |
Why?
| | Chromosome Duplication | 1 | 2014 | 5 | 0.030 |
Why?
| | Endothelium | 1 | 2015 | 133 | 0.030 |
Why?
| | Cell Movement | 1 | 1999 | 936 | 0.030 |
Why?
| | Recombinant Proteins | 3 | 2006 | 1436 | 0.030 |
Why?
| | Chromosomes, Human, Pair 16 | 1 | 2014 | 30 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 352 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2015 | 298 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 1998 | 941 | 0.030 |
Why?
| | Vasoconstrictor Agents | 1 | 2014 | 124 | 0.030 |
Why?
| | Vascular Stiffness | 1 | 2018 | 396 | 0.030 |
Why?
| | Lactates | 1 | 2013 | 94 | 0.030 |
Why?
| | Gene Deletion | 1 | 2015 | 383 | 0.030 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2014 | 96 | 0.030 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 242 | 0.030 |
Why?
| | Dogs | 2 | 1995 | 439 | 0.030 |
Why?
| | Fibrosis | 1 | 2015 | 452 | 0.030 |
Why?
| | Malonyl Coenzyme A | 1 | 2012 | 6 | 0.030 |
Why?
| | Carboxy-Lyases | 1 | 2012 | 10 | 0.030 |
Why?
| | Principal Component Analysis | 1 | 2013 | 184 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2015 | 407 | 0.030 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2012 | 40 | 0.030 |
Why?
| | Atrial Natriuretic Factor | 1 | 2012 | 69 | 0.030 |
Why?
| | Sunlight | 1 | 2013 | 67 | 0.030 |
Why?
| | Action Potentials | 1 | 2015 | 469 | 0.030 |
Why?
| | High-Throughput Screening Assays | 1 | 2013 | 123 | 0.030 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2005 | 2032 | 0.030 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2012 | 138 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2017 | 669 | 0.030 |
Why?
| | Cardioplegic Solutions | 1 | 2011 | 9 | 0.030 |
Why?
| | Phosphorus Radioisotopes | 1 | 2011 | 35 | 0.030 |
Why?
| | Gene Transfer Techniques | 1 | 2012 | 148 | 0.030 |
Why?
| | Buffers | 1 | 2011 | 81 | 0.030 |
Why?
| | Benzamides | 1 | 2012 | 189 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2013 | 780 | 0.030 |
Why?
| | rho Guanine Nucleotide Dissociation Inhibitor alpha | 2 | 2000 | 2 | 0.020 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2012 | 547 | 0.020 |
Why?
| | Regional Blood Flow | 1 | 2012 | 441 | 0.020 |
Why?
| | Connectin | 1 | 2009 | 31 | 0.020 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2009 | 61 | 0.020 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2010 | 146 | 0.020 |
Why?
| | Troponin T | 1 | 2009 | 43 | 0.020 |
Why?
| | Hypertrophy | 1 | 2009 | 124 | 0.020 |
Why?
| | Detergents | 2 | 2000 | 49 | 0.020 |
Why?
| | Neutrophils | 1 | 2015 | 1360 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 1089 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 2011 | 469 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2009 | 308 | 0.020 |
Why?
| | Pyrimidines | 1 | 2012 | 414 | 0.020 |
Why?
| | Young Adult | 2 | 2017 | 11181 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 2 | 2004 | 701 | 0.020 |
Why?
| | Stroke Volume | 1 | 2011 | 544 | 0.020 |
Why?
| | Cytosol | 2 | 1999 | 253 | 0.020 |
Why?
| | Pyridines | 1 | 2012 | 501 | 0.020 |
Why?
| | Phorbol 12,13-Dibutyrate | 2 | 1997 | 14 | 0.020 |
Why?
| | Organ Size | 1 | 2009 | 504 | 0.020 |
Why?
| | Precipitin Tests | 2 | 1997 | 105 | 0.020 |
Why?
| | Contractile Proteins | 1 | 2007 | 18 | 0.020 |
Why?
| | Endothelins | 2 | 1997 | 64 | 0.020 |
Why?
| | Intracellular Membranes | 1 | 2007 | 83 | 0.020 |
Why?
| | Protein Kinase C-alpha | 1 | 2007 | 44 | 0.020 |
Why?
| | Kidney | 1 | 2014 | 1230 | 0.020 |
Why?
| | Pneumonectomy | 1 | 2008 | 126 | 0.020 |
Why?
| | Adult | 3 | 2017 | 32799 | 0.020 |
Why?
| | Genotype | 1 | 2012 | 1878 | 0.020 |
Why?
| | Troponin C | 1 | 2006 | 5 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2013 | 1590 | 0.020 |
Why?
| | Coronary Artery Disease | 1 | 2013 | 702 | 0.020 |
Why?
| | Pressure | 1 | 2007 | 278 | 0.020 |
Why?
| | Fura-2 | 1 | 1995 | 22 | 0.020 |
Why?
| | Receptors, Adrenergic, alpha | 1 | 1995 | 43 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2007 | 361 | 0.020 |
Why?
| | Receptors, Serotonin | 1 | 1995 | 41 | 0.020 |
Why?
| | Propranolol | 1 | 2005 | 69 | 0.020 |
Why?
| | Blood Gas Analysis | 1 | 2005 | 86 | 0.020 |
Why?
| | Heart Transplantation | 1 | 2011 | 738 | 0.020 |
Why?
| | Saccharomyces cerevisiae | 2 | 2000 | 531 | 0.020 |
Why?
| | Protein Kinase C beta | 1 | 2004 | 28 | 0.020 |
Why?
| | Child, Preschool | 1 | 2019 | 9875 | 0.020 |
Why?
| | Survival Analysis | 1 | 2009 | 1420 | 0.020 |
Why?
| | Cytokines | 1 | 2013 | 1990 | 0.020 |
Why?
| | Actins | 1 | 2007 | 369 | 0.020 |
Why?
| | Diastole | 1 | 2005 | 170 | 0.020 |
Why?
| | Enzyme Induction | 1 | 2004 | 99 | 0.020 |
Why?
| | Osteopontin | 1 | 2004 | 37 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2004 | 149 | 0.020 |
Why?
| | Acidosis | 1 | 2005 | 94 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2007 | 885 | 0.020 |
Why?
| | Stroke | 1 | 2013 | 996 | 0.020 |
Why?
| | Muscle Strength | 1 | 2007 | 277 | 0.020 |
Why?
| | Body Weight | 1 | 2009 | 1026 | 0.020 |
Why?
| | Sialoglycoproteins | 1 | 2004 | 180 | 0.020 |
Why?
| | Femoral Artery | 1 | 1995 | 173 | 0.020 |
Why?
| | Lung | 1 | 2017 | 3653 | 0.020 |
Why?
| | Calcium-Binding Proteins | 1 | 2005 | 222 | 0.020 |
Why?
| | Mutation | 2 | 2009 | 3468 | 0.020 |
Why?
| | Intestine, Large | 1 | 1993 | 14 | 0.020 |
Why?
| | Drug Resistance | 1 | 2004 | 188 | 0.020 |
Why?
| | Cardiotonic Agents | 1 | 2004 | 139 | 0.020 |
Why?
| | Carbachol | 1 | 1993 | 22 | 0.020 |
Why?
| | Catechols | 1 | 1993 | 21 | 0.020 |
Why?
| | Algorithms | 1 | 2011 | 1552 | 0.020 |
Why?
| | Quinones | 1 | 1993 | 14 | 0.020 |
Why?
| | Myosins | 1 | 1993 | 130 | 0.020 |
Why?
| | Lactams, Macrocyclic | 1 | 1993 | 49 | 0.010 |
Why?
| | Benzoquinones | 1 | 1993 | 48 | 0.010 |
Why?
| | Protein Binding | 2 | 1999 | 2067 | 0.010 |
Why?
| | Potassium | 1 | 1993 | 147 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2007 | 1247 | 0.010 |
Why?
| | Pulmonary Artery | 1 | 2008 | 1102 | 0.010 |
Why?
| | Cyclic GMP-Dependent Protein Kinases | 1 | 2000 | 5 | 0.010 |
Why?
| | Octoxynol | 1 | 2000 | 11 | 0.010 |
Why?
| | Adenosine Diphosphate Ribose | 1 | 2000 | 9 | 0.010 |
Why?
| | Child | 1 | 2019 | 18757 | 0.010 |
Why?
| | Guanosine Diphosphate | 1 | 2000 | 20 | 0.010 |
Why?
| | Biological Transport, Active | 1 | 2000 | 76 | 0.010 |
Why?
| | Serine Endopeptidases | 1 | 2000 | 102 | 0.010 |
Why?
| | 3T3 Cells | 1 | 2000 | 157 | 0.010 |
Why?
| | Vitronectin | 1 | 1999 | 6 | 0.010 |
Why?
| | Receptors, Urokinase Plasminogen Activator | 1 | 1999 | 13 | 0.010 |
Why?
| | Macromolecular Substances | 1 | 2000 | 237 | 0.010 |
Why?
| | Cell Line | 1 | 2006 | 2937 | 0.010 |
Why?
| | GTP Phosphohydrolases | 1 | 1999 | 68 | 0.010 |
Why?
| | Flavonoids | 1 | 1999 | 77 | 0.010 |
Why?
| | MAP Kinase Kinase 1 | 1 | 1999 | 74 | 0.010 |
Why?
| | Dimerization | 1 | 1999 | 203 | 0.010 |
Why?
| | Liposomes | 1 | 2000 | 171 | 0.010 |
Why?
| | Protein Structure, Secondary | 1 | 1999 | 395 | 0.010 |
Why?
| | Sodium Dodecyl Sulfate | 1 | 1997 | 23 | 0.010 |
Why?
| | Crystallography, X-Ray | 1 | 1999 | 469 | 0.010 |
Why?
| | Cell Adhesion | 1 | 1999 | 469 | 0.010 |
Why?
| | Oligopeptides | 1 | 1999 | 275 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 1999 | 1008 | 0.010 |
Why?
| | Protein Biosynthesis | 1 | 1999 | 413 | 0.010 |
Why?
| | Fluorides | 1 | 1997 | 51 | 0.010 |
Why?
| | Receptors, Cell Surface | 1 | 1999 | 401 | 0.010 |
Why?
| | Aluminum Compounds | 1 | 1997 | 24 | 0.010 |
Why?
| | Hemolysin Proteins | 1 | 1997 | 38 | 0.010 |
Why?
| | Biological Transport | 1 | 1997 | 426 | 0.010 |
Why?
| | Isometric Contraction | 1 | 1997 | 156 | 0.010 |
Why?
| | Solubility | 1 | 1997 | 269 | 0.010 |
Why?
| | Bacterial Toxins | 1 | 1997 | 111 | 0.010 |
Why?
| | Antifungal Agents | 1 | 1997 | 134 | 0.010 |
Why?
| | Protein Conformation | 1 | 1999 | 962 | 0.010 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 1997 | 238 | 0.010 |
Why?
| | Aging | 1 | 2006 | 1737 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2011 | 12249 | 0.010 |
Why?
| | Cell Membrane | 1 | 1997 | 752 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 1999 | 1472 | 0.010 |
Why?
| | Adolescent | 1 | 2011 | 19192 | 0.010 |
Why?
|
|
Walker's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|